ATE517909T1 - Effizientes gewinnungsverfahren von korrekterweise rückgefalteten proteinen - Google Patents

Effizientes gewinnungsverfahren von korrekterweise rückgefalteten proteinen

Info

Publication number
ATE517909T1
ATE517909T1 AT02725004T AT02725004T ATE517909T1 AT E517909 T1 ATE517909 T1 AT E517909T1 AT 02725004 T AT02725004 T AT 02725004T AT 02725004 T AT02725004 T AT 02725004T AT E517909 T1 ATE517909 T1 AT E517909T1
Authority
AT
Austria
Prior art keywords
extraction
efficient process
refolded proteins
correctly refolded
proteins
Prior art date
Application number
AT02725004T
Other languages
English (en)
Inventor
Helmut Sassenfeld
Richard Remmele
Rebecca McCOY
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE517909T1 publication Critical patent/ATE517909T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Measurement Of Radiation (AREA)
AT02725004T 2001-02-23 2002-02-22 Effizientes gewinnungsverfahren von korrekterweise rückgefalteten proteinen ATE517909T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27103301P 2001-02-23 2001-02-23
PCT/US2002/005645 WO2002068455A2 (en) 2001-02-23 2002-02-22 Efficient recovery of correctly refolded proteins

Publications (1)

Publication Number Publication Date
ATE517909T1 true ATE517909T1 (de) 2011-08-15

Family

ID=23033913

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02725004T ATE517909T1 (de) 2001-02-23 2002-02-22 Effizientes gewinnungsverfahren von korrekterweise rückgefalteten proteinen

Country Status (21)

Country Link
US (2) US7157557B2 (de)
EP (1) EP1366062B1 (de)
JP (1) JP2005505494A (de)
KR (1) KR20040052481A (de)
CN (1) CN1547586A (de)
AT (1) ATE517909T1 (de)
AU (1) AU2002255600B2 (de)
BG (1) BG108087A (de)
CA (1) CA2438094C (de)
CZ (1) CZ20032208A3 (de)
EE (1) EE200300408A (de)
ES (1) ES2370235T3 (de)
HK (1) HK1059267A1 (de)
HU (1) HUP0303246A2 (de)
IL (1) IL157446A0 (de)
MX (1) MXPA03007563A (de)
PL (1) PL374045A1 (de)
RU (1) RU2316563C2 (de)
SK (1) SK10472003A3 (de)
WO (1) WO2002068455A2 (de)
ZA (1) ZA200305909B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040052481A (ko) * 2001-02-23 2004-06-23 임뮤넥스 코포레이션 재조합 단백질의 수득률을 증가시키는 방법
EP2520654B8 (de) 2003-08-26 2017-04-19 The Regents of the University of Colorado, a body corporate Serinprotease-Hemmer und deren Verwendung in Verfahren und Zusammensetzungen für die Behandlung bakterieller Infektionen
WO2006060083A1 (en) * 2004-10-22 2006-06-08 Amgen Inc. Methods for refolding polypeptides
NZ554520A (en) * 2004-10-22 2010-03-26 Amgen Inc Methods for refolding of recombinant antibodies
JP2008528006A (ja) * 2005-01-28 2008-07-31 アポロ ライフ サイエンシズ リミテッド 分子およびそのキメラ分子
JP5053264B2 (ja) 2005-05-19 2012-10-17 アムジェン インコーポレイテッド 抗体の安定性を増加させるための組成物および方法
US20080311078A1 (en) 2005-06-14 2008-12-18 Gokarn Yatin R Self-Buffering Protein Formulations
EP1893632B1 (de) * 2005-06-17 2015-08-12 Novo Nordisk Health Care AG Selektive reduktion und derivatisierung manipulierter faktor vii proteine mit mindestens einem nichtnativen zystein
ATE497973T1 (de) 2005-12-22 2011-02-15 Genentech Inc Rekombinante produktion heparinbindender proteine
WO2007102946A2 (en) 2006-01-23 2007-09-13 Amgen Inc. Crystalline polypeptides
SG162834A1 (en) 2006-07-14 2010-07-29 Genentech Inc Refolding of recombinant proteins
MX2009003982A (es) 2006-10-20 2009-04-27 Amgen Inc Formulaciones de polipeptido estables.
LT3597659T (lt) 2007-07-09 2023-05-10 Genentech, Inc. Disulfidinės jungties redukcijos prevencijos būdas gaminant polipeptidą rekombinantiniu būdu
EP2197911A2 (de) * 2007-09-14 2010-06-23 Amgen Inc. Homogene antikörperpopulationen
EA020621B1 (ru) 2009-06-22 2014-12-30 Амген Инк. Рефолдинг белков с использованием химически контролируемого окислительно-восстановительного состояния
EP3660032A1 (de) 2009-06-25 2020-06-03 Amgen, Inc Erfassungs-/reinigungsverfahren für in einem nichtsäugersystem exprimierte proteine
EP2483289B1 (de) 2009-10-02 2019-03-20 Biogen MA Inc. Verfahren zur vorbeugung und entfernung von trisulphid-bindungen
BR112012013330A2 (pt) * 2009-12-02 2017-03-28 Acceleron Pharma Inc composições e métodos para aumentar meia vida do soro de proteínas de fusão fc
HUE042314T2 (hu) 2011-02-07 2019-06-28 Cerenis Therapeutics Holding Sa Lipoprotein komplexek és azok gyártása és alkalmazásai
US8883982B2 (en) 2011-06-08 2014-11-11 Acceleron Pharma, Inc. Compositions and methods for increasing serum half-life
KR20200044138A (ko) 2011-06-24 2020-04-28 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
KR20140137347A (ko) 2012-01-10 2014-12-02 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
US9353165B2 (en) * 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
EP2880169B1 (de) 2012-08-02 2017-05-17 F. Hoffmann-La Roche AG Verfahren zur herstellung monomerer und multimerer moleküle und verwendungen davon
EA031324B1 (ru) 2012-09-11 2018-12-28 Кохерус Байосайенсис, Инк. Правильно свернутый этанерцепт с высокой чистотой и высоким уровнем выхода
AU2014226126B2 (en) 2013-03-08 2019-02-14 Genzyme Corporation Continuous purification of therapeutic proteins
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
AR103172A1 (es) 2014-12-22 2017-04-19 Novartis Ag Reducción selectiva de residuos de cisteina en anticuerpos il-17
EA201990998A1 (ru) 2016-10-21 2019-11-29 Фармацевтические составы и способы их получения
EP3843869A1 (de) 2018-08-31 2021-07-07 Genzyme Corporation Steriles chromatografieharz und verwendung davon in herstellungsprozessen
AU2019356564A1 (en) 2018-10-11 2021-04-29 Amgen Inc. Downstream processing of bispecific antibody constructs
US20240083972A1 (en) 2020-12-22 2024-03-14 Amgen Inc. Cell culture method

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453363A (en) * 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
US4766205A (en) 1985-11-13 1988-08-23 Beatrice Companies, Inc. Method for isolation of recombinant polypeptides in biologically active forms
EP0293785A3 (de) * 1987-05-29 1990-05-02 Oncogen Limited Partnership Klonierung und Expression von transformierendem Affenwachstumsfaktor-SS 1
US4970067A (en) * 1988-12-12 1990-11-13 Helene Curtis, Inc. Method and composition to condition hair and impart semi-permanent hair set retention properties
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
AU648214B2 (en) 1991-12-31 1994-04-14 Lucky Limited Recombinant gene coding for human alpha interferon and expression vector thereof, etc.
US5447851B1 (en) * 1992-04-02 1999-07-06 Univ Texas System Board Of Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
HUT72926A (en) * 1993-08-04 1996-06-28 Ciba Geigy Ag High molecular weight desulphatohirudin
US6310185B1 (en) * 1994-03-08 2001-10-30 Memorial Sloan Kettering Cancer Center Recombinant human anti-Lewis Y antibodies
AU2603995A (en) 1994-05-25 1995-12-18 University Of Nebraska Board Of Regents Biologically active glycoprotein hormones produced in procaryotic cells
JPH09508140A (ja) 1994-07-22 1997-08-19 エフ・ホフマン−ラ ロシュ アーゲー キメラｔｎｆ結合タンパク質を含有する医薬組成物
US5879673A (en) * 1996-01-25 1999-03-09 Genentech, Inc. Administration of thrombopoietin on a single day only
US5935824A (en) * 1996-01-31 1999-08-10 Technologene, Inc. Protein expression system
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
FR2803303B1 (fr) 2000-01-04 2002-05-10 Aventis Pasteur Glycoproteine d'enveloppe du vih modifiee chimiquement
KR20040052481A (ko) * 2001-02-23 2004-06-23 임뮤넥스 코포레이션 재조합 단백질의 수득률을 증가시키는 방법

Also Published As

Publication number Publication date
MXPA03007563A (es) 2003-12-11
HUP0303246A2 (hu) 2003-12-29
CA2438094C (en) 2011-10-11
WO2002068455A2 (en) 2002-09-06
CA2438094A1 (en) 2002-09-06
PL374045A1 (en) 2005-09-19
WO2002068455A3 (en) 2003-09-18
CZ20032208A3 (cs) 2004-01-14
US7157557B2 (en) 2007-01-02
AU2002255600B2 (en) 2008-01-24
US20070270577A1 (en) 2007-11-22
US7544784B2 (en) 2009-06-09
KR20040052481A (ko) 2004-06-23
HK1059267A1 (en) 2004-06-25
EE200300408A (et) 2003-12-15
EP1366062A2 (de) 2003-12-03
JP2005505494A (ja) 2005-02-24
CN1547586A (zh) 2004-11-17
SK10472003A3 (sk) 2004-03-02
US20020182665A1 (en) 2002-12-05
RU2003127830A (ru) 2005-04-10
ZA200305909B (en) 2004-06-04
RU2316563C2 (ru) 2008-02-10
EP1366062B1 (de) 2011-07-27
IL157446A0 (en) 2004-03-28
BG108087A (bg) 2005-04-30
ES2370235T3 (es) 2011-12-13

Similar Documents

Publication Publication Date Title
ATE517909T1 (de) Effizientes gewinnungsverfahren von korrekterweise rückgefalteten proteinen
EA200700917A1 (ru) Способ рефолдинга рекомбинантных антител
AR038568A1 (es) Anticuerpos anti-a beta y su uso
EA200001023A1 (ru) Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью
ATE500323T1 (de) Subtilisin-variante
DE602005009856D1 (de) Verfahren zur reinigung von fsh
WO2001068708A3 (en) Human and humanized fap-alpha-specific antibodies
TW200510450A (en) Soluble fragments of the SARS-CoV spike glycoprotein
DE60315827D1 (de) Verbesserte polysaccharid- und glykokonjugat-vakzine
DE60228603D1 (de) Antigene und vektoren für impfung
AU2001238212A1 (en) Modified fluorescent proteins
ATE316577T1 (de) Das goodpasture-antigen bindende protein
DK1066328T3 (da) Kimært protein, der indeholder en intramolekylær chaperon-lignende sekvens, og dets anvendelse til insulinproduktion
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
DE60230627D1 (de) Ein fusionsprotein
DE60027581D1 (de) Design von immunogene
WO2002062964A3 (en) Ap1 amine oxidase variants
WO2003022883A3 (de) Verwendung eines proteins zur herstellung eines medikaments zur stimulierung des angeborenen unspezifischen immunsystems
WO2004035733A3 (en) Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof
WO2004053117A3 (en) Serine protease
WO1999055885A3 (en) Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
EA200500624A1 (ru) Промотор для il-18bp, его получение и применение
ATE325873T1 (de) Androgenrezeptor-komplex assoziiertes protein
WO2002063009A8 (en) Lp mammalian proteins; related reagents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties